TB Research

Determinants of multidrug-resistant tuberculosis among adults undergoing treatment for tuberculosis in Tigray Region, Ethiopia: a case-control study

Zereabruk K, Kahsay T, Teklemichael H, Aberhe W, Hailay A, Mebrahtom G, Bezabh G

BMJ open respiratory research · 2024-05

Abstract

Background Multidrug-resistant tuberculosis is a type of tuberculosis that is resistant to at least the first-line antituberculosis drugs namely, rifampicin and isoniazid. However, most of these studies were limited only to a single hospital. Therefore, this study aimed to identify the determinants of multidrug-resistant tuberculosis among adults undergoing treatment for tuberculosis in the Tigray region of Ethiopia. Methods Hospital-based unmatched case-control study was conducted from 1 April 2019 to 30 June 2019. A simple random sampling method was used to select the required sample size. Variables at a p value less than 0.25 in bivariate analysis were entered into a multivariable analysis to identify the determinant factors of multidrug-resistant tuberculosis. Finally, the level of significance was declared at p Results Rural residence (adjusted OR (AOR) 2.54; 95% CI 1.34 to 4.83), HIV (AOR 4.5; 95% CI 1.4 to 14.2), relapse (AOR 3.86; 95% CI 1.98 to 7.5), return after lost follow-up (AOR 6.29; 95% CI 1.64 to 24.2), treatment failure (AOR 5.87; 95% CI 1.39 to 24.8) were among the determinants of multidrug-resistant tuberculosis. Conclusion Rural residence, HIV, relapses, return after lost follow-up and treatment failure were the identified determinant factors of multidrug-resistance tuberculosis.

MeSH terms

  • Humans
  • Tuberculosis, Multidrug-Resistant
  • HIV Infections
  • Recurrence
  • Isoniazid
  • Rifampin
  • Antitubercular Agents
  • Treatment Failure
  • Risk Factors
  • Case-Control Studies
  • Adolescent
  • Adult
  • Middle Aged
  • Rural Population
  • Ethiopia
  • Female
  • Male
  • Young Adult
  • Lost to Follow-Up